Myopia And Presbyopia Treatment Market Size, Trends, Share, Growth | Report 2022-2030
The global myopia and presbyopia treatment market was estimated at USD 16.5 billion in 2021 and it is expected to surpass around USD 33.9 billion by 2030, poised to grow at a CAGR of 8.33% from 2022 to 2030.
The market is expected to expand at a CAGR of 8.5% from 2022 to 2030. Growing research and development in the targeted disorders is expected to drive the market considerably over the forecast period. Moreover, the growing prevalence of myopia and high myopia is anticipated to fuel the market growth during the forecast period. Incidences of myopia in the developing countries of Asia Pacific, such as Japan, China, Singapore, and the Republic of Korea, are growing steeply in recent years.
The growing prevalence of myopia and presbyopia is an opportunity for industry players to introduce efficient treatment solutions. Among the developed nations, the U.S. is witnessing a significant boost in the incidence of myopia and presbyopia, especially in individuals over 42 years of age. The introduction of technologically advanced surgical options and high adoption rates in developed countries are expected to boost the market growth in the upcoming years.
Advanced diagnostic and surgical treatment solutions include LASIK, LASEK, and PRK. The integration of these techniques with artificial intelligence and robot-assisted surgical tools is expected to fuel the number of surgical procedures. The introduction of multifocal intraocular lenses and implantable contact lenses is expected to have a positive impact on the market growth.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 16.5 billion |
| Revenue Forecast by 2030 | USD 33.9billion |
| Growth rate from 2022 to 2030 | CAGR of 8.33% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, region |
| Companies Covered |
Ziemer Ophthalmic Systems AG; NIDEK CO., LTD.; Johnson & Johnson Vision; Essilor Ltd.; Zeiss International; ALCON VISION LLC; Bausch & Lomb Incorporated; Haag-Streit UK; Topcon Corporation |
Myopia Treatment Type Insights
The single prescription lenses segment held the largest revenue share of over 30.0% in 2021. This is due to the increasing prevalence of myopia in developing countries. The growing patient pool is contributing to the growing demand for corrective lenses. Features of the surgery such as minimally invasiveness, accuracy, and speed are also affecting the popularity of the surgery, thereby driving the adoption of myopia and presbyopia treatment.
Technologically advanced solutions are helping to significantly decrease average turnaround time for ophthalmic surgeries. The increasing availability of advanced equipment and decreasing services costs are expected to boost the demand for surgeries during the forecast period.
Presbyopia Treatment Type Insights
Prescription lenses captured the largest revenue share of more than 25.0% in 2021. Contact lenses are also categorized as bifocal, multifocal, monovision, and modified monovision. Conductive keratoplasty, LASIK, LASEK, and PRK are effective refractive surgical procedures used for the treatment of presbyopia. LASIK is a widely accepted surgical procedure for the treatment of presbyopia. The surgery involves the reshaping of the cornea to improve far vision. Hence, the high prevalence of these myopia treatment types and growing demand for LASIK surgery are expected to foster the market growth during the forecast period.
The progressive multifocals segment is expected to be the fastest-growing segment over the forecast period owing to the increasing preference for correcting presbyopia. They are widely accepted due to aesthetic and visual advantages, such as image clarity while rejecting image jumping during eye movements. In addition, innovations in multifocals, such as multifocals incorporated with anti-reflexive coating and photochromic lenses, are expected to propel the growth of the segment during the forecast period.
Regional Insights
North America dominated the market with over 20.0% share in 2021 and is expected to maintain its lead over the forecast period owing to the availability of advanced technologies for treating the targeted myopia treatment types and the presence of a large number of market players. Asia Pacific is expected to be the fastest-growing region over the forecast period owing to the geriatric population growth, the high prevalence of eye-related myopia treatment types, and growing medical tourism.
In addition, the rising disposable income of consumers is expected to drive the market for myopia and presbyopia treatment in the APAC region. Europe is expected to witness growth in the coming years owing to the growing geriatric population and increasing awareness regarding the treatment of targeted myopia treatment type.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Myopia And Presbyopia Treatment Market
5.1. COVID-19 Landscape: Myopia And Presbyopia Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Myopia And Presbyopia Treatment Market, By Myopia Treatment Type
8.1. Myopia And Presbyopia Treatment Market, by Myopia Treatment Type, 2022-2030
8.1.1. Corrective
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Surgical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Drugs
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Myopia And Presbyopia Treatment Market, By Presbyopia Treatment Type
9.1. Myopia And Presbyopia Treatment Market, by Presbyopia Treatment Type, 2022-2030
9.1.1. Prescription Lenses
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Contact Lenses
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Intraocular Lenses
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Refractive Surgery
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Myopia And Presbyopia Treatment Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Myopia Treatment Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Presbyopia Treatment Type (2017-2030)
Chapter 11. Company Profiles
11.1. Ziemer Ophthalmic Systems AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. NIDEK CO., LTD.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Johnson & Johnson Vision
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Essilor Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zeiss International
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. ALCON VISION LLC
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bausch & Lomb Incorporated
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Haag-Streit UK
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Topcon Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers